FISH NSCLC Non-Small Cell Lung Cancer ALK1 ROS1 Test
Comprehensive Genetic Analysis for Targeted Lung Cancer Treatment
The FISH NSCLC Non-Small Cell Lung Cancer ALK1 ROS1 Test represents a breakthrough in personalized cancer care, offering precise genetic characterization of non-small cell lung cancer (NSCLC). This advanced diagnostic tool utilizes Fluorescence In Situ Hybridization (FISH) technology to detect specific gene rearrangements that are crucial for determining the most effective targeted therapies. As lung cancer treatment evolves toward precision medicine, this test provides oncologists with essential genetic information to tailor treatment strategies specifically to each patient’s unique cancer profile.
What This Test Measures and Detects
The FISH NSCLC ALK1 ROS1 Test specifically identifies two critical genetic alterations:
- ALK Gene Rearrangements: Detects EML4-ALK fusion and other ALK rearrangements that make tumors responsive to ALK inhibitors
- ROS1 Gene Fusions: Identifies ROS1 rearrangements that predict response to specific targeted therapies
- Chromosomal Abnormalities: Visualizes specific genetic rearrangements at the chromosomal level
- Biomarker Status: Determines eligibility for targeted treatment options
This test provides crucial information about the genetic drivers of NSCLC, enabling physicians to select therapies that specifically target the molecular abnormalities present in each patient’s cancer cells.
Who Should Consider This Test
This advanced genetic testing is particularly important for:
- Patients newly diagnosed with advanced non-small cell lung cancer
- Individuals with metastatic NSCLC seeking targeted therapy options
- Patients who have failed conventional chemotherapy treatments
- Non-smokers or light smokers with lung adenocarcinoma
- Younger patients with lung cancer who may have driver mutations
- Individuals with specific symptoms including persistent cough, chest pain, shortness of breath, or unexplained weight loss
Key Benefits of Genetic Testing for NSCLC
Undergoing the FISH NSCLC ALK1 ROS1 Test offers numerous advantages:
- Personalized Treatment Selection: Identifies patients who may benefit from targeted therapies like crizotinib, ceritinib, or alectinib
- Improved Treatment Outcomes: Targeted therapies often show higher response rates and fewer side effects than conventional chemotherapy
- Comprehensive Genetic Profiling: Provides detailed information about the molecular characteristics of your cancer
- Informed Decision Making: Empowers patients and physicians with crucial genetic information for treatment planning
- Access to Advanced Therapies: Opens doors to cutting-edge treatment options and clinical trials
- Quality of Life Improvement: Targeted therapies typically cause fewer side effects than traditional chemotherapy
Understanding Your Test Results
Your FISH NSCLC ALK1 ROS1 Test results will provide clear guidance for your treatment journey:
- Positive for ALK Rearrangement: Indicates eligibility for ALK inhibitor therapies with potentially excellent response rates
- Positive for ROS1 Rearrangement: Suggests potential benefit from ROS1-targeted treatments
- Double Positive: Rare cases showing both rearrangements require specialized treatment approaches
- Negative Results: Indicates that other treatment options should be explored, including testing for different genetic markers
- Inconclusive Results: May require repeat testing or alternative testing methods
Your oncologist will interpret these results in the context of your overall health, cancer stage, and other clinical factors to develop the most appropriate treatment plan.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| FISH NSCLC Non-Small Cell Lung Cancer ALK1 ROS1 Test | $400 USD | $550 USD |
Nationwide Testing Availability
We have branches across the United States, making advanced genetic testing accessible to patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures that you can access this crucial testing regardless of your location.
Take Control of Your Lung Cancer Treatment
Don’t leave your treatment decisions to chance. The FISH NSCLC ALK1 ROS1 Test provides the genetic information needed to pursue targeted therapies that may offer better outcomes and improved quality of life. With our discounted price of $400 USD, advanced genetic testing is more accessible than ever.
Call us today at +1(267) 388-9828 to schedule your test or speak with our genetic counseling team. Take the first step toward personalized lung cancer treatment and potentially life-changing therapeutic options.
Our experienced team is ready to guide you through the testing process, answer your questions, and help you understand how genetic testing can impact your treatment journey. With sample processing daily by 4 pm and results typically available within 4 working days, you can get the information you need quickly to make informed decisions about your care.
